¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"polymerase chain reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • delayed reaction
    Áö¿¬¹ÝÀÀ
  • depressive reaction
    ¿ì¿ï¹ÝÀÀ
  • dissociative reaction
    ÇØ¸®¹ÝÀÀ
  • donor reaction
    Á¦°øÀÚ¹ÝÀÀ, °ø¿©ÀÚ¹ÝÀÀ
  • dopa reaction
    µµÆÄ¹ÝÀÀ
  • downgrading reaction
    ÇÏÇâ¹ÝÀÀ
  • exergonic reaction
    ¿¡³ÊÁö¹æÃâ¹ÝÀÀ
  • exoergic reaction
    ¿¡³ÊÁö¹æÃâ¹ÝÀÀ
  • exothermic reaction
    ¹ß¿­¹ÝÀÀ
  • explosive reaction
    Æø¹ßÀû¹ÝÀÀ
  • endergonic reaction
    1. ¿¡³ÊÁöÁõ°­¹ÝÀÀ 2. ¿¡³ÊÁöÈí¼ö¹ÝÀÀ
  • endothermic reaction
    Èí¿­¹ÝÀÀ
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • equilibrium reaction
    ÆòÇü¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • delayed reaction
    Áö¿¬¹ÝÀÀ
  • delayed allergic reaction
    Áö¿¬¾Ë·¹¸£±â¹ÝÀÀ
  • delayed cell-mediated reaction
    Áö¿¬¼¼Æ÷¸Å°³¹ÝÀÀ
  • delayed hemolytic transfusion reaction
    Áö¿¬¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
  • depressive reaction
    ¿ì¿ï¹ÝÀÀ
  • dissociative reaction
    ÇØ¸®¹ÝÀÀ
  • donor reaction
    °øÇ÷ÀÚ¹ÝÀÀ
  • dopa reaction
    µµÆÄ¹ÝÀÀ
  • downgrading reaction
    ÇÏÇâ¹ÝÀÀ
  • dry reaction
    °Ç½Ä¹ÝÀÀ
  • early reaction
    Á¶±â¹ÝÀÀ
  • elementary reaction
    ±âº»¹ÝÀÀ
  • elevator reaction
    ½Â°­¹ÝÀÀ
  • emergency reaction
    ±ä±Þ¹ÝÀÀ
  • endergonic reaction
    ¿¡³ÊÁöÈí¼ö¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • group reaction
    Áý´Ü¹ÝÀÀ(̤ËÀËÑËô).
  • heat of reaction
    ¹ÝÀÀ¿­(Úãëëæð).
  • hemagglutination inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ.
  • hemoclastic reaction
    Ç÷±¸ºØ±«¹ÝÀÀ.
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º ¼öÇ÷¹ÝÀÀ.
  • heterogeneous reaction
    ºÒ±ÕÀϹÝÀÀ, ºÒ±ÕÁú¹ÝÀÀ.
  • heterophil(e) antibody reaction
    ÀÌÁ¾Ä£È­(¼º) Ç×ü¹ÝÀÀ(¡­Úãëë).
  • homograft reaction
    µ¿Á¾ÀÌ½ÄÆí¹ÝÀÀ.
  • hyperkinetic reaction
    °ú´Ù¿îµ¿ ¹ÝÀÀ
  • hypersensitive reaction
    °ú¹Î¼º ¹ÝÀÀ(ΦÚÂàõÚãëë).
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypnic reaction
    ¼ö¸é ¹ÝÀÀ(â²ØùÚãëë)
  • hypnic reaction
    ¼ö¸é¹ÝÀÀ(¡­Úãëë).
  • hysteric reaction
    È÷½ºÅ׸®¼º ¹ÝÀÀ.
  • hysteric reaction
    È÷½ºÅ׸®¼º ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã¾ç ¹ÝÀÀ, °ú¹ÎÁõ¼º ¹ÝÀÀ.
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç ¹ÝÀÀ, °ú¹ÎÁõ¼º ¹ÝÀÀ.
  • anniversary reaction
    ±â³äÀÏ ¹ÝÀÀ
  • anorectic reaction
    ½Ä¿å°áÇ̹ÝÀÀ
  • antigen-antibody reaction
    Ç׿ø-Ç×ü¹ÝÀÀ
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ.
  • antitryptic reaction
    Çׯ®¸³½Å ¹ÝÀÀ(~Úãëë).
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ(¡­Úãëë).
  • arm tonus reaction
    »óÁö±Ù ±äÀå ¹ÝÀÀ(ß¾ò¶ÐÉÑÌíåÚãëë).
  • arousal reaction=arousal response
    °¢¼º¹ÝÀÀ(ÊÆá¥Úãëë)
  • arthus reaction
    ¾Æ¸£¼ö½º ¹ÝÀÀ(¡­Úãëë)
  • asthenia reaction
    ¹«·Â¹ÝÀÀ(ÙíÕôÚãëë)
  • atherosclerosis,reaction to injury hypothesis
    ¼Õ»ó¿¡ ´ëÇÑ ¹ÝÀÀ±âÀü
  • atomic reaction
    ¿øÀÚ¹ÝÀÀ.
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ(í»Ê«Øóæ¹Úãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • complement binding reaction
    º¸Ã¼°íÁ¤ ¹ÝÀÀ(ÜÍô÷ͳïÒÚãëë)
  • concerted reaction
    Çùµ¿¹ÝÀÀ(úðÔÒÚãëë)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cyanogen bromide reaction
    ºê·ÒÈ­ ½Ã¾È ¹ÝÀÀ(Úãëë)
  • cycloaddition reaction
    °í¸® ÷°¡¹ÝÀÀÈ­(ôÕÊ¥Úãëëûù)
  • dark reaction
    ¾Ï¹ÝÀÀ(äÞÚãëë)
  • diffusion-limited reaction
    È®»êÁ¦ÇÑ ¹ÝÀÀ(üªß¤ð¤ùÚÚãëë)
  • diphenylamine reaction
    ÀÌ(ì£)Æä´Ò¾Æ¹Î ¹ÝÀÀ(Úãëë)
  • Dische reaction
    µð½¬ ¹ÝÀÀ(Úãëë) (ÔÒ) diphenyulamine reaction
  • displacement reaction
    ´ëÄ¡ ¹ÝÀÀ(ÓÛöÇÚãëë)
  • disproportionation reaction
    ºÒ±Õµî¹ÝÀÀ(ÝÕгÔõÚãëë)
  • downhill reaction
    ³»¸®¸· ¹ÝÀÀ(Úãëë) (ÔÒ) exergonic reaction
  • Ehrlich reaction
    ¿¡¸¦¸®È÷ ¹ÝÀÀ(Úãëë)
  • elimination reaction
    Á¦°Å ¹ÝÀÀ(ð¶ËÛÚãëë)
  • endergonic reaction
    ¿¡³ÊÁöÈí¼ö ¹ÝÀÀ(ýåâ¥Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
SCC   1) Sude Chain-Cleavage Complex
  2) Squamous Cell Carcinoma
VLCFA Very Long Chain Fatty Acids
BCAA branched chain amino acid
BCKA branched-chain keto acid
BCKD branched-chain alpha-keto acid dehydrogenase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
RT-PCR Reverse transcription and polymerase chain reaction
RT-PCR Reverse transcription and the polymerase chain reaction
RT-PCR Reverse transcription coupled to polymerase chain reaction
RT-PCR Reverse transcription followed by Polymerase Chain Reaction
RT-PCR Reverse transcription followed by the polymerase chain reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • photoallergic reaction
    ±¤¾Ë·¹¸£±â ¹ÝÀÀ
  • photodynamic reaction
    ±¤¿ªÇÐ ¹ÝÀÀ
  • potosensitivity reaction
    ±¤¼± °ú¹ÎÁõ ¹ÝÀÀ
  • psychogenic reaction
    ½ÉÀμº ¹ÝÀÀ
  • psychotic depressive reaction
    Á¤½Åº´Àû ¿ì¿ïÁõ, Á¤½Åº´¼º ¿ì¿ï ¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • reaction formation
    ¹Ýµ¿ Çü¼º
    ¾ïÁ¦µÈ ¹Ý»çȸÀûÀÎ Ãæµ¿°ú´Â »ó¹ÝµÇ°í ¶ÇÇÑ ±×°ÍÀÇ ´ë½ÅÀÌ µÇ´Â ¾î¶² ŵµ¸¦ ¹«ÀǽÄÀûÀ¸·Î ÃëÇÏ°Ô µÇ´Â Á¤½Å ±â±¸.
  • reaction of identity
    ÀÏÄ¡ ¹ÝÀÀ
  • reaction of partial identity
    ºÎºÐ ÀÏÄ¡ ¹ÝÀÀ
  • reaction threshold
    ¹ÝÀÀ ¿ªÄ¡
    ÀÚ±ØÀ» ÁØ ÈÄ ¹ÝÀÀÀÌ ÀϾ±â±îÁöÀÇ °ª.
  • reversible reaction
    °¡¿ª ¹ÝÀÀ
  • scratch reaction
    ¼ÒÆÄ ¹ÝÀÀ
    Áï½ÃÇü ¾Ë·¯Áö ÁúȯÀÇ Áø´Ü¹ý.
  • serologic reaction
    Ç÷û ¹ÝÀÀ, Ç÷ûÇÐÀû ¹ÝÀÀ
  • serum colloidal reaction
    Ç÷û ±³Áú ¹ÝÀÀ
    °£ ±â´É °Ë»çÀÇ Á¾·ù.
  • serum reaction
    Ç÷û ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀ» ½ÃÇè°ü ³»¿¡¼­ ÀçÇöÇÒ ¼ö ÀÖ´Â ¹ÝÀÀ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
immunoglobulins, mu-chain Heavy chains found in the fab and fc fragments of IgM and having a molecular weight of approximately 72 kD. They contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG.
(12 Dec 1998)
invariant chain <chemical> Noncovalently associated with class II antigens, alpha and beta chain complex; involved in the regulation of malignant cell ia function; iip31 and iip33 were synthesized by using alternative initiator methionines
Synonym: II igc, ia-associated invariant chain, II invariant glycoprotein complex, class II-associated invariant chain, IIp33, IIp31, clip peptide, ln-2 antigen, ln 2 antigen, cd74 antigen, II-key, II76-92
(05 Dec 1998)
open chain compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
ossicular chain The small bones of the middle ear; they are articulated to form a chain for the transmission of sound from the tympanic membrane to the oval window.
Synonym: ossicula auditus, ear bones, ossicular chain.
(05 Mar 2000)
EDTA light chain <protein> Myosin light chains (18 kD) from scallop muscle (two per pair of heavy chains), easily extracted by calcium chelation. Although the EDTA light chains do not bind calcium they confer calcium sensitivity on the myosin heavy chains.
(18 Nov 1997)
electron transport chain <biochemistry, chemistry> A series of compounds that transfer electrons to an eventual donor with concomitant energy conversion.
One of the best studied is in the mitochondrial inner membrane, that takes NADH (from the tricarboxylic acid cycle) or FADH and transfers electrons via ubiquinone, cytochromes and various other compounds, to oxygen. Other electron transport chains are involved in photosynthesis.
(18 Nov 1997)
J chain <molecular biology> A polypeptide chain (15 kD), found in IgA and in IgM joining heavy chains (H chains) to each other to form dimers of IgA and pentamers of IgM. Disulphide bonds are formed between the J chain and H chains near the Fc ends of the heavy chains. Despite the similar name, it is not identical with the J region or coded for by the J gene.
Synonym: J piece.
(10 Jan 1998)
kappa chain <protein> Either of two types of light chains (small polypeptide chains) that are found in immunoglobulins.
(09 Oct 1997)
2-methyl branched-chain enoyl-CoA reductase <enzyme> Important in the reversal of beta-oxidation under anaerobic conditions in ascaris suum
Registry number: EC 1.3.1.52
Synonym: 2-methyl bce-CoA reductase
(26 Jun 1999)
lambda chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
lauric acid in-chain-hydroxylase <enzyme> Specific for lauric acid; hydroxylates at c-8, c-9 or c-10 of chain
Registry number: EC 1.14.14.-
Synonym: (cytochrome p-450)-dependent laurate in-chain-hydroxylase
(26 Jun 1999)
L chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
L-chain disease bence Jones myeloma
L-chain myeloma bence Jones myeloma
light chain <immunology, protein> The lighter of the two types of polypeptide chains that are found in immunoglobulin and antibody molecules.
Also used as a non-specific term for the smaller subunits of several multimeric proteins such as immunoglobulin, myosin, dynein, clathrin.
(14 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á